MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 113 filers reported holding MACROGENICS INC in Q2 2017. The put-call ratio across all filers is 1.11 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,059,869 | -12.9% | 1,300,401 | +0.0% | 0.00% | – |
Q2 2023 | $6,956,610 | -25.6% | 1,300,301 | -0.2% | 0.00% | -100.0% |
Q1 2023 | $9,344,417 | -46.1% | 1,303,266 | -49.5% | 0.00% | 0.0% |
Q4 2022 | $17,330,762 | +263.7% | 2,582,826 | +87.5% | 0.00% | – |
Q3 2022 | $4,765,000 | +27.3% | 1,377,304 | +8.6% | 0.00% | – |
Q2 2022 | $3,742,000 | -88.0% | 1,268,554 | -64.2% | 0.00% | -100.0% |
Q1 2022 | $31,229,000 | -33.2% | 3,544,724 | +21.7% | 0.00% | 0.0% |
Q4 2021 | $46,748,000 | -24.1% | 2,912,670 | -1.0% | 0.00% | -33.3% |
Q3 2021 | $61,622,000 | -29.0% | 2,942,781 | -8.9% | 0.00% | -40.0% |
Q2 2021 | $86,800,000 | +2.1% | 3,231,559 | +21.1% | 0.01% | 0.0% |
Q1 2021 | $85,013,000 | +44.3% | 2,669,170 | +3.6% | 0.01% | +25.0% |
Q4 2020 | $58,919,000 | +1.3% | 2,577,363 | +11.6% | 0.00% | 0.0% |
Q3 2020 | $58,181,000 | +32.8% | 2,309,668 | +47.2% | 0.00% | +33.3% |
Q2 2020 | $43,814,000 | +293.0% | 1,569,280 | -18.1% | 0.00% | +200.0% |
Q1 2020 | $11,150,000 | -46.9% | 1,915,848 | -0.8% | 0.00% | 0.0% |
Q4 2019 | $21,005,000 | -12.7% | 1,930,610 | +2.3% | 0.00% | -50.0% |
Q3 2019 | $24,073,000 | -45.9% | 1,886,618 | -28.1% | 0.00% | -33.3% |
Q2 2019 | $44,527,000 | +73.9% | 2,623,875 | +84.3% | 0.00% | +50.0% |
Q1 2019 | $25,598,000 | +49.8% | 1,423,718 | +5.8% | 0.00% | 0.0% |
Q4 2018 | $17,088,000 | -35.7% | 1,345,529 | +8.6% | 0.00% | 0.0% |
Q3 2018 | $26,564,000 | -15.2% | 1,239,115 | -18.3% | 0.00% | -33.3% |
Q2 2018 | $31,325,000 | +19.6% | 1,517,112 | +45.8% | 0.00% | +50.0% |
Q1 2018 | $26,188,000 | +31.8% | 1,040,602 | -0.5% | 0.00% | 0.0% |
Q4 2017 | $19,871,000 | +7.1% | 1,045,936 | +4.2% | 0.00% | 0.0% |
Q3 2017 | $18,561,000 | +9.3% | 1,004,217 | +3.6% | 0.00% | 0.0% |
Q2 2017 | $16,974,000 | -9.4% | 969,221 | -3.8% | 0.00% | 0.0% |
Q1 2017 | $18,732,000 | +9.2% | 1,007,211 | +20.0% | 0.00% | 0.0% |
Q4 2016 | $17,152,000 | -31.0% | 839,491 | +1.0% | 0.00% | -33.3% |
Q3 2016 | $24,852,000 | +28.7% | 830,830 | +16.1% | 0.00% | +50.0% |
Q2 2016 | $19,309,000 | +27.1% | 715,507 | -11.6% | 0.00% | 0.0% |
Q1 2016 | $15,189,000 | -36.8% | 809,705 | +4.3% | 0.00% | -33.3% |
Q4 2015 | $24,048,000 | -23.0% | 776,396 | -46.7% | 0.00% | -25.0% |
Q3 2015 | $31,218,000 | -31.6% | 1,457,609 | +21.2% | 0.00% | -20.0% |
Q2 2015 | $45,655,000 | +50.4% | 1,202,329 | +24.3% | 0.01% | +66.7% |
Q1 2015 | $30,346,000 | +180.2% | 967,366 | +213.4% | 0.00% | +200.0% |
Q4 2014 | $10,832,000 | +85.6% | 308,709 | +10.6% | 0.00% | 0.0% |
Q3 2014 | $5,835,000 | -4.8% | 279,206 | -1.0% | 0.00% | 0.0% |
Q2 2014 | $6,132,000 | +130.1% | 282,122 | +194.6% | 0.00% | – |
Q1 2014 | $2,665,000 | +24.8% | 95,749 | +22.9% | 0.00% | – |
Q4 2013 | $2,135,000 | – | 77,912 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Boxer Capital, LLC | 2,115,000 | $37,034,000 | 8.81% |
INTERWEST VENTURE MANAGEMENT CO | 1,074,316 | $18,811,000 | 4.45% |
DAFNA Capital Management LLC | 119,200 | $2,087,000 | 1.49% |
BB BIOTECH AG | 2,350,112 | $41,150,000 | 1.26% |
TIGER MANAGEMENT L.L.C. | 239,667 | $4,197,000 | 0.82% |
Hood River Capital Management LLC | 576,193 | $10,089,000 | 0.70% |
Bellevue Group AG | 316,418 | $5,540,000 | 0.66% |
Rhenman & Partners Asset Management AB | 175,000 | $3,064,000 | 0.44% |
First Light Asset Management, LLC | 61,538 | $1,078,000 | 0.36% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 54,000 | $945,000 | 0.36% |